These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36212264)

  • 1. ASSOCIATION BETWEEN PRO12ALa POLYMORPHISM OF PPARγ2 GENE AND CORONARY ARTERY DISEASE IN IRANIAN POPULATION WITH TYPE TWO DIABETES MELLITUS.
    Saremi L; Lotfipanah S; Feizy F; Ghaffari ME; Babaniamansour S; Saltanatpour Z
    Acta Endocrinol (Buchar); 2022; 18(2):139-144. PubMed ID: 36212264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Klupa T; Skupien J; Walus M; Mlynarski W; Sieradzki J
    Diabetes Res Clin Pract; 2003 Nov; 62(2):105-11. PubMed ID: 14581147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-γ polymorphism (rs1801282) is associated with obesity in Egyptian patients with coronary artery disease and type 2 diabetes mellitus.
    Hasan NS; Kamel SA; Hamed M; Awadallah E; Rahman AHA; Musa NI; Hussein GHS
    J Genet Eng Biotechnol; 2017 Dec; 15(2):409-414. PubMed ID: 30647679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
    Wan J; Xiong S; Chao S; Xiao J; Ma Y; Wang J; Roy S
    Cardiovasc Diabetol; 2010 Mar; 9():13. PubMed ID: 20334678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population.
    Majid M; Masood A; Kadla SA; Hameed I; Ganai BA
    Biochem Genet; 2017 Feb; 55(1):10-21. PubMed ID: 27567620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the PPARγ2 Pro12Ala polymorphism with increased risk of cardiovascular diseases.
    Li Y; Zhu J; Ding JQ
    Genet Mol Res; 2015 Dec; 14(4):18662-74. PubMed ID: 26782516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between PPARγ2 Pro12Ala polymorphism and type 2 diabetes mellitus in Chinese Han population: a Meta-analysis].
    Tong JY; Huang N; Wang L; Yi YS; Pan XH; Lü Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Apr; 46(4):359-63. PubMed ID: 22800638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects.
    Rhee EJ; Kwon CH; Lee WY; Kim SY; Jung CH; Kim BJ; Sung KC; Kim BS; Oh KW; Kang JH; Park SW; Kim SW; Lee MH; Park JR
    Circ J; 2007 Mar; 71(3):338-42. PubMed ID: 17322631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygosity for the Ala allele of the PPARγ2 Pro12Ala polymorphism is associated with reduced risk of coronary artery disease.
    Galgani A; Valdes A; Erlich HA; Mano C; Cheng S; Petrone A; Sentinelli F; Berni A; Baroni MG; Buzzetti R
    Dis Markers; 2010; 29(5):259-64. PubMed ID: 21206011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
    Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
    Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population.
    Rooki H; Haerian MS; Azimzadeh P; Ebrahimi M; Mirhafez R; Ferns G; Ghayour-Mobarhan M; Zali MR
    Indian J Hum Genet; 2013 Oct; 19(4):423-9. PubMed ID: 24497707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension.
    Rodríguez-Esparragón FJ; Rodríguez-Pérez JC; Macías-Reyes A; Alamo-Santana F
    J Hypertens; 2003 Sep; 21(9):1649-55. PubMed ID: 12923396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
    Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
    Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.
    Rooki H; Haerian MS; Azimzadeh P; Mirhafez R; Ebrahimi M; Ferns G; Ghayour-Mobarhan M; Zali MR
    Mol Biol Rep; 2014 May; 41(5):3127-33. PubMed ID: 24464185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.
    Zouari Bouassida K; Chouchane L; Jellouli K; Chérif S; Haddad S; Gabbouj S; Danguir J
    Diabetes Metab; 2005 Apr; 31(2):119-23. PubMed ID: 15959417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles.
    Rahimi Z; Chamaie-Nejad F; Saeidi S; Rahimi Z; Ebrahimi A; Shakiba E; Vaisi-Raygani A
    Int J Fertil Steril; 2018 Jul; 12(2):147-151. PubMed ID: 29707932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population.
    Namvaran F; Rahimi-Moghaddam P; Azarpira N
    J Res Med Sci; 2011 Mar; 16(3):291-6. PubMed ID: 22091247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.